前收市價 | 11,352.00 |
開市 | 0.00 |
買盤 | 0.00 x 0 |
賣出價 | 0.00 x 0 |
今日波幅 | 0.00 - 0.00 |
52 週波幅 | |
成交量 | |
平均成交量 | 2,921,220 |
市值 | 186.431B |
Beta 值 (5 年,每月) | 0.19 |
市盈率 (最近 12 個月) | 39.17 |
每股盈利 (最近 12 個月) | 3.07 |
業績公佈日 | 2024年7月25日 |
遠期股息及收益率 | 2.28 (2.01%) |
除息日 | 2024年2月22日 |
1 年預測目標價 | 125.31 |
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease drugs.